Detalles de la búsqueda
1.
BCL-2 Inhibitor ABT-737 Effectively Targets Leukemia-Initiating Cells with Differential Regulation of Relevant Genes Leading to Extended Survival in a NRAS/BCL-2 Mouse Model of High Risk-Myelodysplastic Syndrome.
Int J Mol Sci
; 22(19)2021 Sep 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-34638998
2.
BCL-2 inhibition with ABT-737 prolongs survival in an NRAS/BCL-2 mouse model of AML by targeting primitive LSK and progenitor cells.
Blood
; 122(16): 2864-76, 2013 Oct 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-23943652
3.
The proneural gene ASCL1 governs the transcriptional subgroup affiliation in glioblastoma stem cells by directly repressing the mesenchymal gene NDRG1.
Cell Death Differ
; 26(9): 1813-1831, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30538287
4.
GEP analysis validates high risk MDS and acute myeloid leukemia post MDS mice models and highlights novel dysregulated pathways.
J Hematol Oncol
; 9: 5, 2016 Jan 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-26817437
5.
DNA-mediated adjuvant immunotherapy extends survival in two different mouse models of myeloid malignancies.
Oncotarget
; 6(32): 32494-508, 2015 Oct 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-26378812
Resultados
1 -
5
de 5
1
Próxima >
>>